(Q71975331)
Statements
Phase II trial of oral altretamine for relapsed ovarian carcinoma: evaluation of defining response by serum CA125 (English)
G J Rustin
A E Nelstrop
M Crawford
J Ledermann
H E Lambert
R Coleman
J Johnson
H Evans
S Brown